Diseases caused by S. pyogenes are a worldwide problem. The determination of GAS prevalence and emm typing is an added value to studies of streptococcal diseases. The M typing system, including emm typing, plays a significant role in the understanding of the GAS epidemiology. As far as we know, this research is the first attempt at S. pyogenes characterization through emm typing in Morocco.
A global estimate of cases of GAS infections was carried out in 2005. It was found that over 616 million incident cases per year of GAS pharyngitis are in developing countries and GAS was considered the 9th leading cause of death due to infection (
1). In a study done from March 2006 to February 2007 in four primary health care centers in Rabat and Sale cities in Morocco, the overall prevalence of GAS was 9.3% and it was 9.1% in children (
19). In our study, the prevalence of GAS was 6.2%, lower than that estimated by the work of Barbosa and al. (23%) (
20). A meta-analysis study found that the prevalence of GAS in 14 studies analyzed was 37%. However, the authors highlighted a high heterogeneity in these studies and the prevalence was ranged from 17% to 58% (
21). Another study in Northern India found a prevalence of 2.8 % of children with GAS, which is lower than our results (
22).
In addition,
emm typing revealed 7
emm profiles and
emm90 was the most prevalent type with a frequency of 30.77%, followed by
emm89 (23.08%) and
emm12 (15.38%). Studies done in Sweden and Brazil reported that just one child with pharyngitis presented the type
emm90 (3.1% and 0.92%, respectively), which is lower than our result (
23,
24). The studies done by the French National Reference Center for Streptococci and Chen and al. linked this type of
emm to invasive GAS infections (
25,
26). However, other studies showed that
emm90 was involved in a severe epidemic of GAS pharyngitis (
7,
16). Few studies found that
emm90 is related to GAS pharyngitis because it is a new M type and it is rarely isolated (
27).
The distribution of the
emm types varies depending on the region. In studies done in Canada, India, and Italy, it was found that
emm12 was the most prevalent
emm type among children with GAS pharyngitis (
28-
30). In a study done in Lebanon, Bahnan and al. reported that the most prevalent
emm types were
emm1,
emm22, and
emm28 (
31). Moreover, in Tunisia, it was shown that
emm118,
emm42, and
emm28 were the most predominant types (
32). There were no similarities in the types of
emm between different studies and ours. This could be explained by the specific geographic conditions and differences in climate in different regions of the world that may affect the diversity of
emm gene (
2). We also found that
emm 75 had the lowest frequency. This Result is similar to the study in Iran and Tokyo that revealed that
emm 75 was the least prevalent isolated
emm type (
33,
34).
The distribution of the
emm types varies depending on the season. In our study,
emm 90 and
emm75 peaked in autumn. However, in the study done in the US,
emm90 (cluster E2) and
emm75 (cluster E6) peaked in summer (
35,
36). Other studies done in Western Norway and Finland indicated that a peak of GAS incidence occurred during winter and summer. The most presented
emm types were
emm1 and
emm28, while the
emm 75 was less presented in this series (
37,
38)
Due to the small sample size, the distribution of the
emm types according to age was not examined. This is similar to the observation of the study that was done in Japan (
34).
As reported by several studies, all our tested isolates were sensitive to penicillin G (
18,
28,
31-
33). Hence, penicillin remains the drug of choice for treating GAS infections. In case of allergy to penicillin, researchers recommend erythromycin as the best therapeutic alternative for streptococcal infection in the oral cavity. However, over the last few years, some countries reported resistance to erythromycin because of the overuse of the drug. In our study, 9.1% of cases were found resistant to erythromycin, which is lower than the percentage that was found in Brazil, Lebanon, and Spain (15.4%, 10%, and 10.6%, respectively) (
18,
31,
39). This percentage of resistance to erythromycin is higher than the observations of the studies that were done in India, Tunisia, Iran, and Turkey (5.6%, 4.8%, 0%, and 3.8%, respectively) (
28,
32,
33,
40). Moreover, the studies conducted in Germany and Italy reported an incremental increase of resistance to erythromycin in GAS strains (24% and 35.8%, respectively) (
41,
42). GAS still has good sensitivity to penicillin and can be applied in the treatment of bacterial pharyngitis.
Although the ARF cases were not developed in our study, and the complications of tonsillitis are rare, it still presents a risk to acquire the post -streptococcal infections.
5.1. Limitations
This study has some limitations. Firstly, children were diagnosed in just one health center, which indicates that the number of cases included in our study was too small. Secondly, we tested 200 children with sore throats and we tried to exclude 23 those with antibiotic consumption. Finally, some children or their parents refused to make a throat swab sample. Because of these reasons, the number of GAS recovered from this study population was low and we could not find any significant relationship between emm types, and age and antibiotic resistance.
5.2. Conclusions
Despite the fact that the positive GAS number in our work was low, we can conclude that emm90 is the most prevalent type in the region. Also, penicillin and erythromycin are still the treatment choices for GAS pharyngitis cases. The emm typing is useful for molecular studies of GAS and provides new information on the diversity of the emm gene. A higher number of isolates could be considered in the future to validate this genetic diversity. Although this study revealed no complications of GAS pharyngitis, the majority of cases of ARF, mentioned in the last study in Morocco, had a history of acute pharyngitis. Thus, this result indicates the importance of considering GAS pharyngitis in the future and its virulence to prevent children who have many episodes of pharyngitis to develop post-streptococcal complications.